EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predictive value of molecular matching tools for the development of donor specific HLA ‐antibodies in patients undergoing lung transplantation

Lisa Kleid, Julia Walter, Maximilian Vorstandlechner, Christian P Schneider, Sebastian Michel, Nikolaus Kneidinger, Michael Irlbeck, Christian Wichmann, Patrick Möhnle, Andreas Humpe, Teresa Kauke iD, Andrea Dick

HLA · 2023

DOI: 10.1111/tan.15068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2023. Verfasst von Lisa Kleid und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Immunogenetics, Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germ…. Hauptthemen laut MEDLINE: Kidney Transplantation, Lung Transplantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular matching is a new approach for virtual histocompatibility testing in organ transplantation. The aim of our study was to analyze whether the risk for de novo donor‐specific HLA antibodies (dnDSA) after lung transplantation (LTX) can be predicted by molecular matching algorithms (MMA) and their combination. In this retrospective study we included 183 patients undergoing LTX at our center from 2012–2020. We monitored dnDSA development for 1 year. Eplet mismatches (epMM) using HLAMatchmaker were calculated and highly immunogenic eplets based on their ElliPro scores were identified. PIRCHE‐II scores were calculated using PIRCHE‐II algorithm (5‐ and 11‐loci). We compared epMM and PIRCHE‐II scores between patients with and without dnDSA using t‐test and used ROC‐curves to determine optimal cut‐off values to categorize patients into four groups. We used logistic regression with AIC to compare the predictive value of PIRCHE‐II, epMM, and their combination. In total 28.4% of patients developed dnDSA ( n = 52), 12.5% class I dnDSA ( n = 23), 24.6% class II dnDSA ( n = 45), and 8.7% both class II and II dnDSA ( n = 16). Mean epMMs ( p ‐value = 0.005), mean highly immunogenic epMMs ( p ‐value = 0.003), and PIRCHE‐II (11‐loci) ( p = 0.01) were higher in patients with compared to without class II dnDSA. Patients with highly immunogenic epMMs above 30.5 and PIRCHE‐II 11‐loci above 560.0 were more likely to develop dnDSA (31.1% vs. 14.8%, p ‐value = 0.03). The logistic regression model including the grouping variable showed the best predictive value. MMA can support clinicians to identify patients at higher or lower risk for developing class II dnDSA and might be helpful tools for immunological risk assessment in LTX patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationLung TransplantationHumansRetrospective StudiesGraft RejectionAllelesAntibodiesHistocompatibility TestingHLA AntigensTissue DonorsIsoantibodies

Stichwörter der Autor:innen

donor-specific HLA-antibodiesepitope matchinglung transplantationmolecular matching algorithms

Substanzen

AntibodiesHLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Laboratory for Immunogenetics, Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Division of Thoracic Surgery, University Hospital, LMU Munich, Munich, Germany.
  • Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany.
  • Department of Medicine V, University Hospital, LMU Munich, Munich, Germany.
  • Department of Cardiac Surgery, University Hospital, LMU Munich, Munich, Germany.

ORCID-Profile: Teresa Kauke

Zitieren

APA

Kleid, L., Walter, J., Vorstandlechner, M., Schneider, C. P., Michel, S., Kneidinger, N., Irlbeck, M., Wichmann, C., Möhnle, P., Humpe, A., Kauke, T., & Dick, A. (2023). Predictive value of molecular matching tools for the development of donor specific HLA ‐antibodies in patients undergoing lung transplantation. HLA. https://doi.org/10.1111/tan.15068

Vancouver

Kleid L, Walter J, Vorstandlechner M, Schneider CP, Michel S, Kneidinger N, et al. Predictive value of molecular matching tools for the development of donor specific HLA ‐antibodies in patients undergoing lung transplantation. HLA. 2023. doi:10.1111/tan.15068

BibTeX
@article{Kleid2023,
  author = {Kleid, Lisa and Walter, Julia and Vorstandlechner, Maximilian and Schneider, Christian P and Michel, Sebastian and Kneidinger, Nikolaus and Irlbeck, Michael and Wichmann, Christian and Möhnle, Patrick and Humpe, Andreas and Kauke, Teresa and Dick, Andrea},
  title = {Predictive value of molecular matching tools for the development of donor specific HLA ‐antibodies in patients undergoing lung transplantation},
  journal = {HLA},
  year = {2023},
  doi = {10.1111/tan.15068}
}
Kostenlos starten →